Intercept Pharmaceuticals reported $-10064000 in EBITDA for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Alnylam Pharmaceuticals ALNY:US USD -247440000 65.85M
Amarin AMRN:US USD 56.56M 93.4M
Amgen AMGN:US USD 3.5B 62M
Arrowhead Research ARWR:US USD -81170000 10.86M
AstraZeneca AZN:LN USD 3.6B 404M
Biogen BIIB:US USD 992.8M 82.9M
Bluebird Bio BLUE:US USD -85093000 14.32M
Bristol Myers Squibb BMY:US USD 5.32B 456M
Eli Lilly And LLY:US USD 2.31B 308.9M
Esperion Therapeutics ESPR:US USD -41518000 10.71M
Gilead Sciences GILD:US USD 3.28B 731M
GlaxoSmithKline GSK:LN GBP 3.36B 916M
Intercept Pharmaceuticals ICPT:US USD -10064000 808K
IONIS PHARMACEUT IONS:US USD -54729000 26.4M
Moderna Inc MRNA:US USD 1.28B 1.24B
Neurocrine Biosciences NBIX:US USD 91.8M 33.2M
Novartis NOVN:VX USD 4.69B 34M
Ptc Therapeutics PTCT:US USD -33710000 29.47M
Regeneron Pharmaceuticals REGN:US USD 1.33B 49.4M
Sangamo Biosciences SGMO:US USD -51845000 8.99M
Sarepta Therapeutics SRPT:US USD -120652000 80.59M
Vertex Pharmaceuticals VRTX:US USD 1.16B 6.8M
YTE INCY:US USD 134.94M 141.85M